U.S, November 29, 2019 (CANNABISNOW) Fear-driven misinformation is permeating the national conversation about the vaping-related deaths. Here’s what you need to know.
A wave of vaping-related pulmonary illness is shaking up America. The first reported illnesses first broke out over the summer and have now killed dozens and sickened thousands...
U.S, November 27, 2019 (ANALYTICALCANNABIS) Cannabis may be a promising alternative for chronic pain sufferers who are turning to illicit opioids to manage their symptoms, according to the results of a new study.
Previous scientific studies have documented the behavior of chronic pain patients who are using cannabis as an alternative pain...
U.S, February 11, 2020 (ANALYTICALCANNABIS) Memories aren’t always trustworthy, especially, it seems, when cannabis is involved.
In a new study published this Monday, researchers found that people can double their number of “false memories” after inhaling marijuana fumes. In a series of virtual...
U.S, February 10, 2020 (GREENMARKETREPORT) Cannabis, to some, is seen as a risky market. Bankers, the government, and society, in general, all have their own hesitations with the industry. This rings true for investors, too. FINANCIAL-investors-tell-cannabis-companies-prove-it-before-opening-wallet
Some financial experts are adamant about the importance...
U.S, December 21, 2019 (INDEPENDENT) Thousands of people with severe epilepsy will be able to access a cannabis-based treatment on the NHS from the new year, it has been revealed.
Epidyolex, a cannabidiol (CBD) oral medication, has been fast-tracked by the health service in England to be available from 6...
CANADA, October 2 2019 (ANALYTICALCANNABIS) Researchers at Western University, Canada, have uncovered the exact molecular mechanisms that cause CBD to block some of the negative psychiatric side effects associated with high levels of THC in cannabis.
Their study, the results of which were recently published in the Journal of Neuroscience, identified extracellular-signal regulated...